Ozeki M, Fukao T (2019) Generalized lymphatic anomaly and Gorham-Stout disease: overview and recent insights. Adv Wound Care (New Rochelle) 8:230–245

Article  PubMed  Google Scholar 

de Keyser CE, Saltzherr MS, Bos EM, Zillikens MC (2020) A large skull defect due to Gorham-Stout disease: case report and literature review on pathogenesis, diagnosis, and treatment. Front Endocrinol (Lausanne) 11:1–7

Article  Google Scholar 

Pepe J, Rossi M, Battafarano G, Vernocchi P, Conte F, Marzano V, Mariani E, Mortera SL, Cipriani C, Rana I, Buonuomo PS, Bartuli A, De Martino V, Pelle S, Pascucci L, Toniolo RM, Putignani L, Minisola S, Del Fattore A (2022) Characterization of extracellular vesicles in osteoporotic patients compared to osteopenic and healthy controls. J Bone Miner Res 37:2186–2200

Article  CAS  PubMed  Google Scholar 

Chen T, Wang Y, Hao Z, Hu Y, Li J (2021) Parathyroid hormone and its related peptides in bone metabolism. Biochem Pharmacol 192:114669–114685

Article  CAS  PubMed  Google Scholar 

Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55:331–343

Article  CAS  PubMed  Google Scholar 

Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21:207–218

Article  CAS  PubMed  Google Scholar 

Franco-Barrera MJ, Zavala-Cerna MG, Aguilar-Portillo G, Sánchez-Gomez DB, Torres-Bugarin O, Franco-Barrera MA, Roa-Encarnacion CM (2017) Gorham-Stout disease: a clinical case report and immunological mechanisms in bone erosion. Clin Rev Allergy Immunol 52:125–132

Article  CAS  PubMed  Google Scholar 

Rossi M, Buonuomo PS, Battafarano G, Conforti A, Mariani E, Algeri M, Pelle S, D’Agostini M, Macchiaiolo M, De Vito R, Gonfiantini MV, Jenkner A, Rana I, Bartuli A, Del Fattore A (2020) Dissecting the mechanisms of bone loss in Gorham-Stout disease. Bone 130:115068

Article  CAS  PubMed  Google Scholar 

Hominick D, Silva A, Khurana N, Liu Y, Dechow PC, Feng JQ, Pytowski B, Rutkowski JM, Alitalo K, Dellinger MT (2018) VEGF-C promotes the development of lymphatics in bone and bone loss. Elife 7:1–22

Article  Google Scholar 

Dorsey TB, Kim D, Grath A, James D, Dai G (2018) Multivalent biomaterial platform to control the distinct arterial venous differentiation of pluripotent stem cells. Biomaterials 185:1–12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D, Hughes ED, Saunders TL, Wu J, Vasquez MNH, Makinen T, King PD (2022) Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells. JCI Insight 7:1–20

Article  Google Scholar 

Akangire G, Menden H, Xia S, Thiffault I, Ahmed A, Sampath V (2022) EPHB4 mutation suppresses PROX1 expression and disrupts lymphatic development in neonatal hydrops. Pediatrics 149:e2021053294

Article  PubMed  Google Scholar 

Greene AK, Brouillard P, Sudduth CL, Smits PJ, Konczyk DJ, Vikkula M (2021) EPHB4 mutation causes adult and adolescent-onset primary lymphedema. Am J Med Genet A 185:3810–3813

Article  CAS  PubMed  Google Scholar 

Zhang Y, Kou Y, Yang P, Rong X, Tang R, Liu H, Li M (2022) ED-71 inhibited osteoclastogenesis by enhancing EphrinB2-EphB4 signaling between osteoclasts and osteoblasts in osteoporosis. Cell Signal 96:110376

Article  CAS  PubMed  Google Scholar 

Jiang Y, Tao G, Guan Y, Chen S, He Y, Li T, Zou S, Li Y (2023) The role of ephrinB2-EphB4 signalling in bone remodelling during orthodontic tooth movement. Orthod Craniofac Res 26:107–116

Article  PubMed  Google Scholar 

Zeng X, Hunt A, Jin SC, Duran D, Gaillard J, Kahle KT (2019) EphrinB2-EphB4-RASA1 signaling in human cerebrovascular development and disease. Trends Mol Med 25:265–286

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kondo T, Kanayama K, Egusa H, Nishimura I (2023) Current perspectives of residual ridge resorption: pathological activation of oral barrier osteoclasts. J Prosthodont Res 67:12–22

Article  PubMed  Google Scholar 

Elera-Fitzcarrald C, Ugarte-Gil MF (2020) Gorham-Stout syndrome: a phantom bone disease treated with bisphosphonates. J Clin Rheumatol 26:135–136

Article  Google Scholar 

Schneider KN, Masthoff M, Gosheger G, Klingebiel S, Schorn D, Röder J, Vogler T, Wildgruber M, Andreou D (2020) Gorham-Stout disease: good results of bisphosphonate treatment in 6 of 7 patients. Acta Orthop 91:209–214

Article  PubMed  PubMed Central  Google Scholar 

Cramer SL, Wei S, Merrow AC, Pressey JG (2016) Gorham-Stout disease successfully treated with sirolimus and zoledronic acid therapy. J Pediatr Hematol Oncol 38:e129–e132

Article  CAS  PubMed  Google Scholar 

Liu M, Liu W, Qiao C, Han B (2017) Mandibular Gorham-Stout disease: a case report and literature review. Medicine (Baltimore) 96:e8184

Article  PubMed  Google Scholar 

Kendler DL, Bone HG, Massari F, Gielen E, Palacios S, Maddox J, Yan C, Yue S, Dinavahi RV, Libanati C, Grauer A (2019) Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab. Osteoporos Int 30:2437–2448

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsai JN, Lee H, David NL, Eastell R, Leder BZ (2019) Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. Lancet Diabetes Endocrinol 7:767–775

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Wang H, Lv C, Huang L, Zhang C, Zhou C, Zou S, Duan P (2021) Intermittent parathyroid hormone promotes cementogenesis via ephrinB2-EPHB4 forward signaling. J Cell Physiol 236:2070–2086

Article  CAS  PubMed  Google Scholar 

Krege JH, Gilsenan AW, Komacko JL, Kellier-Steele N (2022) Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates. JBMR Plus 6:e10665

Article  CAS  PubMed  PubMed Central  Google Scholar